By BA Laris, MPH | February 26, 2019

Today, cancer is the leading cause of death of people living with HIV (PLWH). A study published in the Annals of Internal Medicine showed that between 1996 and 2009, there was a 50% increase in cancers of people living with HIV compared to the general population. Non-AIDS-related cancer deaths increased from 11% to 22%. People living with HIV had higher rates for 4 out of 5 forms of cancer. 

By Michael Everett, MHS | May 22, 2018

Advocacy is an extraordinary and powerful tool. This is a strategy that can tailor itself to the unique needs and culture of any service-related organization. It’s also genuinely exciting to offer technical assistance to organizations interested in putting advocacy to work.

These are just some of the reasons ETR’s team embraces any opportunity we are given to support organizations in building advocacy skills and practices.

By BA Laris, MPH & Nic Carlisle, JD | March 29, 2018

When you hear the term “HIV and AIDS advocacy,” what do you think of? In our work we have found there are typically two responses:

“Yes! This is how we get our voice heard!”

“Umm, well, I am glad people are working on these issues, but I don’t really know how that all actually works.”

By Michael Everett, MHS | September 25, 2017

As we gear up for National Gay Men's HIV/AIDS Awareness Day, I have a message for you from my gay brothers. That’s right. Not to them, but from us to you. We need your help! Yes, you!

For the last 30+ years, HIV has been instrumental in drawing attention to the experiences of gay men in the United States

By Ayn N. Whyte, MS—Diné | March 14, 2017
STD/HIV/AIDS Prevention Program Manager, Albuquerque Area Indian Health Board

As many of our communities prepare to recognize National Native HIV/AIDS Awareness Day, I am compelled to honor the group of individuals who envisioned and made this day a reality. I am blessed to work today with many of these people in raising awareness and promoting testing among our people. 

By Jim Pickett | October 11, 2016
Director of Prevention Advocacy and Gay Men's Health, AIDS Foundation of Chicago

PrEP has altered the landscape in HIV prevention in extraordinary and profound ways. It’s changing the lives of vulnerable individuals. It’s also bringing about big changes for the HIV workforce—health care providers, prevention specialists, outreach workers, social workers, educators and more. In fact, I believe we’ve entered the most dynamic period in our fight against HIV since 1996, when the advent of highly active antiretroviral therapy revolutionized treatment and saved countless lives.

By Marcia Quackenbush, MS, MFT, MCHES | September 6, 2016

In 2012, the U.S. Food and Drug Administration approved oral Truvada for pre-exposure prophylaxis of HIV (PrEP). In a very short period of time, PrEP has substantially changed the HIV prevention landscape. It’s effective (when taken) and has an excellent safety profile.

How well is it working in different populations? I took a quick dive into some recent reports to get an update.

By Melissa Donze | July 25, 2016
MPH Candidate, Columbia University Mailman School of Public Health & ETR Kirby Summer Intern

It’s hard to forget your first time on Capitol Hill. I was first there in the fall of 2012. I had just started working as the Pedro Zamora Public Policy Fellow at AIDS United (a DC-based nonprofit focused on ending the HIV epidemic in the United States through strategic grantmaking and policy/advocacy).

I remember how incredible it felt to walk those marble halls where so many great policymakers had walked before me. I remember how inspired I felt to see fellow advocates preparing for meetings with high-level members of Congress.